SK281980B6 - Kryštallický (+)l-hydrogenvínan, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie - Google Patents

Kryštallický (+)l-hydrogenvínan, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie Download PDF

Info

Publication number
SK281980B6
SK281980B6 SK1520-95A SK152095A SK281980B6 SK 281980 B6 SK281980 B6 SK 281980B6 SK 152095 A SK152095 A SK 152095A SK 281980 B6 SK281980 B6 SK 281980B6
Authority
SK
Slovakia
Prior art keywords
thiadiazol
hexyloxy
methylpyridine
tetrahydro
crystalline
Prior art date
Application number
SK1520-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK152095A3 (en
Inventor
Linda Marie Osborne
Lisa Ann Shipley
Svend Treppendahl
Torben Guldager Petersen
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of SK152095A3 publication Critical patent/SK152095A3/sk
Publication of SK281980B6 publication Critical patent/SK281980B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1520-95A 1993-06-04 1994-05-26 Kryštallický (+)l-hydrogenvínan, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie SK281980B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7257293A 1993-06-04 1993-06-04
PCT/DK1994/000205 WO1994029303A1 (fr) 1993-06-04 1994-05-26 Produit chimique heterocyclique

Publications (2)

Publication Number Publication Date
SK152095A3 SK152095A3 (en) 1996-10-02
SK281980B6 true SK281980B6 (sk) 2001-09-11

Family

ID=22108479

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1520-95A SK281980B6 (sk) 1993-06-04 1994-05-26 Kryštallický (+)l-hydrogenvínan, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie

Country Status (22)

Country Link
US (1) US5834495A (fr)
EP (1) EP0703915B1 (fr)
JP (1) JP3190679B2 (fr)
KR (1) KR100339115B1 (fr)
CN (1) CN1064681C (fr)
AT (1) ATE196631T1 (fr)
AU (1) AU698673B2 (fr)
CA (1) CA2164296C (fr)
CZ (1) CZ290550B6 (fr)
DE (1) DE69426021T2 (fr)
DK (1) DK0703915T3 (fr)
ES (1) ES2152315T3 (fr)
FI (1) FI955829A (fr)
GR (1) GR3035033T3 (fr)
HU (1) HUT75038A (fr)
IL (1) IL109866A (fr)
NO (1) NO305560B1 (fr)
NZ (2) NZ267062A (fr)
PT (1) PT703915E (fr)
SK (1) SK281980B6 (fr)
WO (1) WO1994029303A1 (fr)
ZA (1) ZA943904B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043258A (en) * 1996-08-01 2000-03-28 Eli Lilly And Company Method for treating disruptive behavior disorders with xanomeline
EP0821954A1 (fr) * 1996-08-01 1998-02-04 Eli Lilly And Company Méthode de traitement d'arriération mentale
EP0821956A1 (fr) * 1996-08-01 1998-02-04 Eli Lilly And Company Méthode de traitement de troubles disruptifs de comportement
US6117890A (en) * 1996-08-01 2000-09-12 Eli Lilly And Company Method for treating bipolar disorder
US6090829A (en) * 1996-08-01 2000-07-18 Eli Lilly And Company Method for treating excessive aggression
US6034108A (en) * 1997-07-28 2000-03-07 Eli Lilly And Company Method for treating mental retardation
CA2978201A1 (fr) 2015-03-06 2016-09-15 Chase Pharmaceuticals Corporation Utilisation de formulations transdermiques d'oxybutynine pour reduire les effets secondaires associes aux agonistes muscariniques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264444A (en) * 1989-02-22 1993-11-23 Novo Nordisk A/S Piperidine compounds and use
US5260311A (en) * 1989-02-22 1993-11-09 Novo Nordisk A/S Piperidine compounds and their use
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use

Also Published As

Publication number Publication date
ES2152315T3 (es) 2001-02-01
FI955829A0 (fi) 1995-12-04
NO954892L (no) 1995-12-01
AU698673B2 (en) 1998-11-05
CA2164296C (fr) 2007-01-23
HU9503453D0 (en) 1996-01-29
CN1128999A (zh) 1996-08-14
PT703915E (pt) 2001-03-30
GR3035033T3 (en) 2001-03-30
AU6924294A (en) 1995-01-03
IL109866A0 (en) 1994-10-07
NZ267062A (en) 1999-09-29
NO305560B1 (no) 1999-06-21
CA2164296A1 (fr) 1994-12-22
US5834495A (en) 1998-11-10
IL109866A (en) 2000-06-01
KR100339115B1 (ko) 2002-11-07
DE69426021T2 (de) 2001-05-17
SK152095A3 (en) 1996-10-02
NO954892D0 (no) 1995-12-01
JP3190679B2 (ja) 2001-07-23
FI955829A (fi) 1995-12-04
KR960702835A (ko) 1996-05-23
CZ321095A3 (en) 1996-09-11
CN1064681C (zh) 2001-04-18
HUT75038A (en) 1997-03-28
CZ290550B6 (cs) 2002-08-14
ZA943904B (en) 1995-12-04
JPH08511008A (ja) 1996-11-19
WO1994029303A1 (fr) 1994-12-22
NZ336733A (en) 2001-02-23
DE69426021D1 (de) 2000-11-02
EP0703915A1 (fr) 1996-04-03
EP0703915B1 (fr) 2000-09-27
DK0703915T3 (da) 2001-01-22
ATE196631T1 (de) 2000-10-15

Similar Documents

Publication Publication Date Title
JPS6049192B2 (ja) 新規置換ベンズアミド、その製造方法及びこれを有効成分とする向精神薬
EP0579681B1 (fr) Monohydrate d'hydrochlorure de tiagabine cristalline, sa preparation et son utilisation
HU197842B (en) Process for producing pharmaceutical compositions comprising 2-alkoxy-n-(1-azabicyclo/2.2.2/oct-3-yl)-benzamide derivatives
JPS636058B2 (fr)
CA2164296C (fr) Chimie heterocyclique
AU2003251974B2 (en) Novel salt and polymorphs of desloratadine hemifumarate
MXPA03005884A (es) Hemimaleato de amlodipina.
KR100476606B1 (ko) 결정질 아자비시클로(2,2,2)옥탄-3-아민 시트레이트의다형체 및 그의 제약 조성물
JPH09504014A (ja) カルシウムチャネル拮抗薬としてのアミン誘導体類
CZ20014270A3 (cs) Polymorfy krystalického citrátu (2-benzhydryl-1-azabicyklo[2.2.2]oct-3-yl)-(5-iso-propyl-2-methoxybenzyl)-aminu jako antagonisté receptoru NK-1
GB2057446A (en) 1,2,4-triazole-3-thiols
JP3681770B2 (ja) 老年性痴呆症又はアルツハイマー病治療剤
JP2825643B2 (ja) 新規アリールオキシーアルキルアミン、その製法及びこれを含有する心臓循環系疾患治療用の医薬品
AU2001100436A4 (en) Amlodipine hemimaleate
RU2173146C2 (ru) Производные полициклических алкалоидов как антагонисты nmda-рецептора
JPH072786A (ja) ピラゾール化合物
WO2007139497A1 (fr) Dérivés levoglucosenone pour le traitement de troubles tels que cancer, maladies auto-immunes et maladies du cœur.
JPH03163079A (ja) キサンチン誘導体、それらを有効成分とする気管支拡張剤及び脳機能改善剤
JPH03151366A (ja) 9―アミノアセチルアミノテトラヒドロアクリジン誘導体
EP0369696A2 (fr) Sulfonamides de quinolizine comme agents antinéoplastiques
CS226200B2 (cs) Způsob výroby derivátů 4-amino-5-alkylsulfonylorthoanisamidů
MXPA98009242A (en) Salt mesylate trihydrate 5 - (- 2- (4- (1,2-benzoisotiazol-3-il) -1-piperazinil) ethyl) -6-chlorine-1,3-dihydro-2h-indol-2-
MXPA98009293A (en) Hydrogen smoke of (-) - 3r, 4r-trans-7-metoxy-2,2-dimethyl-3-fenil-4. { 4- [2- (pirrolidin-1-il) etoxy] fenil} crystal crystal
WO2003042161A1 (fr) Polymorphes de chlorhydrate de venlafaxine
CS209950B2 (en) Method of making the new 4- amino-6,7-dialcoxy-2-piperazinochinazoline derivatives